1. Effective Management of Psoriatic Arthritis: Tailoring Treatments

2. Psoriatic Arthritis Clinical Manifestations

3. Psoriatic Arthritis Clinical Manifestations (cont)

4. Psoriatic Arthritis Clinical Manifestations (cont)

5. Psoriatic Arthritis Comorbidities

6. Psoriatic Arthritis Contributing Factors to Psoriasis

7. Key Cells and Mediators: Transition From Innate to Adaptive Immunity

8. Pathogenesis of Psoriatic Arthritis

9. Treatment of Psoriatic Arthritis

10. Newer Treatment Options

11. Emerging Treatments for Psoriatic Arthritis

12. Treatment of Psoriatic Arthritis The Pathophysiologic Cascade

13. Cytokine Signaling Pathways cAMP/PKA

14. Ustekinumab Inhibits p40 Moiety

15. IL-17 Inhibitors

16. Cytokine Signaling Pathways JAK

17. Mechanism of Action of Abatacept

18. Guselkumab: IL-23, p19

19. New Domain Core Set for Psoriatic Arthritis

20. Core Domains to Evaluate in Clinical Trials

21. GRAPPA 2015 Treatment Recommendations

22. GRAPPA 2015 Treatment Recommendations: Peripheral Arthritis

23. GRAPPA 2015 Treatment Recommendations: Axial Disease

24. GRAPPA 2015 Treatment Recommendations: Enthesitis and Dactylitis

25. GRAPPA 2015 Treatment Recommendations: Skin and Nails

26. Case: Aggressive Disease 55-Year-Old Man

27. Joint Examination

28. Choosing a Therapy

29. GRAPPA Minimal Disease Activity Criteria

30. Case: Disease Progression 40-Year-Old Woman

31. Evaluation for Inflammatory Back Pain

32. Treatment and Management

33. Concluding Remarks

34. Abbreviations

35. Abbreviations (cont)

36. Abbreviations (cont)

37. Abbreviations (cont)